Chemtros Balance Sheet Health
Financial Health criteria checks 4/6
Chemtros has a total shareholder equity of ₩65.1B and total debt of ₩27.7B, which brings its debt-to-equity ratio to 42.5%. Its total assets and total liabilities are ₩123.3B and ₩58.2B respectively. Chemtros's EBIT is ₩5.2B making its interest coverage ratio 1.7. It has cash and short-term investments of ₩32.9B.
Key information
42.5%
Debt to equity ratio
₩27.65b
Debt
| Interest coverage ratio | 1.7x |
| Cash | ₩32.88b |
| Equity | ₩65.10b |
| Total liabilities | ₩58.22b |
| Total assets | ₩123.32b |
Recent financial health updates
Recent updates
We Think You Should Be Aware Of Some Concerning Factors In Chemtros' (KOSDAQ:220260) Earnings
Nov 26
More Unpleasant Surprises Could Be In Store For Chemtros Co., Ltd.'s (KOSDAQ:220260) Shares After Tumbling 28%
Nov 13Chemtros Co., Ltd.'s (KOSDAQ:220260) Price Is Out Of Tune With Earnings
Jul 03Solid Earnings May Not Tell The Whole Story For Chemtros (KOSDAQ:220260)
May 26Chemtros Co., Ltd. (KOSDAQ:220260) Looks Just Right With A 28% Price Jump
Mar 04There Are Reasons To Feel Uneasy About Chemtros' (KOSDAQ:220260) Returns On Capital
Mar 30These 4 Measures Indicate That Chemtros (KOSDAQ:220260) Is Using Debt Extensively
Mar 01Chemtros Co., Ltd.'s (KOSDAQ:220260) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 02Shareholders Are Thrilled That The Chemtros (KOSDAQ:220260) Share Price Increased 154%
Jan 05
Is Chemtros (KOSDAQ:220260) Shrinking?
Dec 10Financial Position Analysis
Short Term Liabilities: A220260's short term assets (₩57.0B) exceed its short term liabilities (₩54.7B).
Long Term Liabilities: A220260's short term assets (₩57.0B) exceed its long term liabilities (₩3.5B).
Debt to Equity History and Analysis
Debt Level: A220260 has more cash than its total debt.
Reducing Debt: A220260's debt to equity ratio has increased from 30.2% to 42.5% over the past 5 years.
Debt Coverage: A220260's debt is well covered by operating cash flow (27.8%).
Interest Coverage: A220260's interest payments on its debt are not well covered by EBIT (1.7x coverage).